维普中文期刊产品整合服务
11篇 您的检索式:作者名="Martin Hartman"
    题名 作者 年代 出处 被引量
1Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer显示文摘Martin Sj?str?m Linda Hartman Dorthe Grabau Tommy Fornander Per Malmstr?m Bo Nordenskj?ld Dennis C. Sgroi Lambert Skoog Olle St?l L. M. Fredrik Leeb-Lundberg M?rten Fern? 2014Breast Cancer Research and Treatment2014,,:1
2Generalized model for NOx and N2O emissions from soils显示文摘PARTON WJ HOLLADN EA DEL GROSSO SJ HARTMAN MD MARTIN RE MOSIER AR OJIMA DS SCHIMEL DS 2001Journal of Geophysical Research2001,1,06:1
3A Space-Time Permutation Scan Statistic for Disease Outbreak Detection 显示文摘Martin K Richard H Hartman J 2005PLoS Medicine2005,2,3:1
4Characterization of petrophysical flow units in carbonate reservoirs显示文摘Martin A J Sclomon S T Hartman D J 1997AAPG Bulletin1997,81,6:1
5显示文摘 de Bont Jan A M Hartmans Sybe 1995Biotechnol Bioeng1995,45,2:1
6应用卡巴拉汀治疗轻到中重度阿尔茨海默病患者52周有效性研究(译文)显示文摘卡巴拉汀酒石酸盐 ( ENA71 3,艾斯能 )是具有中枢活性的胆碱酯酶抑制剂。通过为期 2 6周、双盲、安慰剂对照研究后 ,又进行了为期 2 6周的开放标记扩展临床研究 ,以评估其治疗轻到中重度阿尔茨海默病的有效性。结果表明 ,服用卡巴拉汀 6~ 1 2 mg/d共 5 2周的患者 ,认知功能明显好于以前服用安慰剂者。Martin Farlow Ravi Anand John Messina Jr Richard Hartman Jeffrey Veach 2002中国神经免疫学和神经病学杂志2002,9,2:1
7l, et aL Benchmark data and power calculations for evaluating disease outbreak detection methods显示文摘Martin K Zhang Z Hartman 2004MMWR2004,53,9:1
8Health spending growth at a historic low in 2008显示文摘Hartman M Martin A Nuccio O 2010Health Affairs2010,29,1:1
9Characterization of petrophysical flow units in carbonate reservoirs显示文摘MARTIN A J SCLOMON S T HARTMAN D J 1997AAPG Bulletin1997,81,6:1
10A monolithic silicon photodetector/amplifier IC for fiber and integrated optics application显示文摘Hartman Dabis H Grace Martin K Ryan Carl R 1985Journal of Lightwave Technology1985,3,4:1
11Test of incremental respiratory endurance as home-based, standalone therapy in chronic obstructive pulmonary disease: A case report显示文摘BACKGROUND The prevalence of chronic obstructive pulmonary disease(COPD)is increasing worldwide,and at the same time it is associated with increased mortality and reduced quality of life.Efforts to build sustainable rehabilitation approaches to COPD treatment and prevention are crucial.The system of long-term pulmonary rehabilitation care is insufficient.The main reasons for the absence of these outpatient programs are the lack of experience,the lack of interest of insurance companies in secondary prevention programs,and the lack of healthcare facilities in large geographical areas.The possibility of at-home pulmonary rehabilitation models(telemonitoring and telecoaching)could solve this problem.CASE SUMMARY A 71-year-old man with severe COPD,Global Initiative for Obstructive Lung Diseases stage 3 underwent an 8-wk remotely monitored inspiratory muscle training with a device based on the test of incremental respiratory endurance method.Spirometry,body plethysmography,test of incremental respiratory endurance examination,6-min walking test,body mass index,airflow obstruction,dyspnea,exercise capacity index,and subjective perception of dyspnea were performed as part of the initial and final examination.The patient performed training at home,and the physiotherapist monitored the patient remotely through a web application that allowed the physiotherapist to evaluate all training parameters in real-time and respond to any problems.After 8 wk of home training,there was a significant increase in all monitored values:maximal inspiratory pressure,a novel parameter sustained maximal inspiratory pressure,forced expiratory volume in 1 s,total lung capacity,forced vital capacity,peak expiratory flow,and inspiratory capacity.There was also an improvement in the perception of dyspnea according to the COPD Assessment Test and a modified Medical Research Council Breathlessness Scale,an increase in exercise tolerance according to the 6-min walking test,and a decrease in the exercise capacity index as a predictor of prognosis.CONCLUSION Respiratory telerehabilitation was greatly beneficial in a cooperative patient with COPD and may represent an alternative therapeutic approach to the increasing incidence of all lung diseases.Filip Dosbaba Martin Hartman Ladislav Batalik Kristian Brat Marek Plutinsky Jakub Hnatiak Magno F Formiga Lawrence Patrick Cahalin 2022World Journal of Clinical Cases2022,10,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费